• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型香豆素酰胺类化合物对人碳酸酐酶IX和XII的抑制活性及对A549细胞的抗增殖活性研究

Investigation on Human Carbonic Anhydrase IX and XII Inhibitory Activity and A549 Antiproliferative Activity of a New Class of Coumarinamides.

作者信息

Moi Davide, Carradori Simone, Gallorini Marialucia, Mencarelli Noemi, Deplano Alberto, Angeli Andrea, Vittorio Serena, Supuran Claudiu T, Onnis Valentina

机构信息

Department of Life and Environmental Sciences, Unit of Pharmaceuitical, Pharmacological and Nutraceutical Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, I-09042 Monserrato, CA, Italy.

Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Via dei Vestini 31, I-66100 Chieti, CH, Italy.

出版信息

Pharmaceuticals (Basel). 2025 Mar 5;18(3):372. doi: 10.3390/ph18030372.

DOI:10.3390/ph18030372
PMID:40143148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11944513/
Abstract

-Aggressive solid tumors are commonly characterized by both basic intracellular pH and acidic extracellular pH, which increase cell survival and proliferation. As carbonic anhydrases IX/XII are involved in this pH regulation, their inhibition is an appealing approach in cancer therapy, avoiding cancer cell survival and proliferation. Substituted coumarins are selective non-classical CA IX and CA XII inhibitors. -In this study, new 7-hydroxycoumarinamides were synthesized and assayed for CA inhibition and antiproliferative activity. -All of the coumarinamides showed human CA IX and CA XII selective inhibition over the off-target CA I and CA II isoforms. Coumarin acts as a suicide inhibitor because its heterocyclic ring can be hydrolyzed by CA esterase activity to give the corresponding 2-hydroxycinnamic acid derivative which blocks the entrance of the active site. The 2-hydroxycinnamic acid derivatives deriving from the most potent and selective coumarinamides were docked into CA IX and XII to better understand the activity and selectivity against the two CA isoforms. The most active coumarinamides also produced a decrease of A549 cell proliferation and were able to arrest cells at the G1/S checkpoint. -These results may open new perspectives for developing coumarin-based CA IX/XII inhibitors.

摘要

侵袭性实体瘤通常具有细胞内碱性pH值和细胞外酸性pH值的特征,这会增加细胞的存活和增殖。由于碳酸酐酶IX/XII参与这种pH调节,抑制它们是癌症治疗中一种有吸引力的方法,可避免癌细胞的存活和增殖。取代香豆素是选择性非经典CA IX和CA XII抑制剂。

在本研究中,合成了新型7-羟基香豆素酰胺,并检测了其对碳酸酐酶的抑制作用和抗增殖活性。

所有香豆素酰胺对脱靶的CA I和CA II同工型均表现出对人CA IX和CA XII的选择性抑制。香豆素作为一种自杀性抑制剂,因为其杂环可被CA酯酶活性水解,生成相应的2-羟基肉桂酸衍生物,该衍生物会阻断活性位点的入口。将源自最有效和选择性最强的香豆素酰胺的2-羟基肉桂酸衍生物对接至CA IX和XII中,以更好地了解其对这两种CA同工型的活性和选择性。活性最强的香豆素酰胺还能降低A549细胞的增殖,并能够使细胞停滞在G1/S检查点。

这些结果可能为开发基于香豆素的CA IX/XII抑制剂开辟新的前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/d507ae57125e/pharmaceuticals-18-00372-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/9bc6da4d7431/pharmaceuticals-18-00372-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/58bc48a8b97f/pharmaceuticals-18-00372-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/4fde8296702c/pharmaceuticals-18-00372-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/6e806e528883/pharmaceuticals-18-00372-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/3e583fea55c5/pharmaceuticals-18-00372-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/827474c0944b/pharmaceuticals-18-00372-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/1d918dd23d89/pharmaceuticals-18-00372-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/d507ae57125e/pharmaceuticals-18-00372-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/9bc6da4d7431/pharmaceuticals-18-00372-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/58bc48a8b97f/pharmaceuticals-18-00372-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/4fde8296702c/pharmaceuticals-18-00372-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/6e806e528883/pharmaceuticals-18-00372-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/3e583fea55c5/pharmaceuticals-18-00372-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/827474c0944b/pharmaceuticals-18-00372-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/1d918dd23d89/pharmaceuticals-18-00372-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c1/11944513/d507ae57125e/pharmaceuticals-18-00372-g006.jpg

相似文献

1
Investigation on Human Carbonic Anhydrase IX and XII Inhibitory Activity and A549 Antiproliferative Activity of a New Class of Coumarinamides.新型香豆素酰胺类化合物对人碳酸酐酶IX和XII的抑制活性及对A549细胞的抗增殖活性研究
Pharmaceuticals (Basel). 2025 Mar 5;18(3):372. doi: 10.3390/ph18030372.
2
Synthesis and biological evaluation of new 3-substituted coumarin derivatives as selective inhibitors of human carbonic anhydrase IX and XII.新型 3-取代香豆素衍生物的合成及作为人碳酸酐酶 IX 和 XII 的选择性抑制剂的生物评价。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2185760. doi: 10.1080/14756366.2023.2185760.
3
Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffold.基于功能化香豆素骨架的碳酸酐酶 IX 和 XII 选择性抑制剂。
Drug Dev Res. 2023 Jun;84(4):681-702. doi: 10.1002/ddr.22049. Epub 2023 Mar 5.
4
Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity.深入研究具有磺酰胺或羧酸官能团的香豆素芳基烯胺酮对碳酸酐酶抑制活性和选择性的影响。
Bioorg Chem. 2022 Sep;126:105888. doi: 10.1016/j.bioorg.2022.105888. Epub 2022 May 25.
5
Coumarin and Piperazine Conjugates as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII Isoforms.香豆素与哌嗪衍生物作为肿瘤相关碳酸酐酶 IX 和 XII 同工型的选择性抑制剂。
Anticancer Agents Med Chem. 2023;23(10):1184-1191. doi: 10.2174/1871520623666230202123535.
6
Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis.新型 3-取代香豆素作为选择性人碳酸酐酶 IX 和 XII 抑制剂的研究:合成、生物学及分子动力学分析。
Eur J Med Chem. 2021 Jan 1;209:112897. doi: 10.1016/j.ejmech.2020.112897. Epub 2020 Oct 1.
7
Synthesis and biological evaluation of coumarin-1,3,4-oxadiazole hybrids as selective carbonic anhydrase IX and XII inhibitors.香豆素-1,3,4-噁二唑杂合体的合成与生物评价作为选择性碳酸酐酶 IX 和 XII 抑制剂。
Bioorg Chem. 2019 Jun;87:765-772. doi: 10.1016/j.bioorg.2019.04.004. Epub 2019 Apr 5.
8
New 7-hydroxycoumarin acetamide derivatives as human carbonic anhydrase IX and XII inhibitors: Design, synthesis, biological evaluation and molecular docking studies.新型7-羟基香豆素乙酰胺衍生物作为人碳酸酐酶IX和XII抑制剂:设计、合成、生物学评价及分子对接研究
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400482. doi: 10.1002/ardp.202400482.
9
Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors.新型 4,7-二取代香豆素的合成及作为选择性肿瘤相关碳酸酐酶 IX 和 XII 抑制剂的生物评价。
Bioorg Med Chem Lett. 2021 May 1;39:127877. doi: 10.1016/j.bmcl.2021.127877. Epub 2021 Feb 26.
10
Novel benzenesulfonamide derivatives as potential selective carbonic anhydrase IX, XII inhibitors with anti-proliferative activity: Design, synthesis and in silico studies.新型苯磺酰胺衍生物作为具有抗增殖活性的潜在选择性碳酸酐酶IX、XII抑制剂:设计、合成及计算机模拟研究
Bioorg Chem. 2024 Dec;153:107881. doi: 10.1016/j.bioorg.2024.107881. Epub 2024 Oct 10.

引用本文的文献

1
Characterization of the Antiproliferative and Antimetastatic Properties of Meroterpenoid Centrapalus Coumarin F.半萜类化合物Centrapalus香豆素F的抗增殖和抗转移特性表征
Int J Mol Sci. 2025 May 8;26(10):4489. doi: 10.3390/ijms26104489.

本文引用的文献

1
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity.癌症中的缺氧诱导因子:从通路调节到治疗机遇
BMJ Oncol. 2024 Feb 1;3(1):e000154. doi: 10.1136/bmjonc-2023-000154. eCollection 2024.
2
4-(Pyrazolyl)benzenesulfonamide Ureas as Carbonic Anhydrases Inhibitors and Hypoxia-Mediated Chemo-Sensitizing Agents in Colorectal Cancer Cells.4-(吡唑基)苯磺酰胺脲类作为碳酸酐酶抑制剂和低氧介导的结直肠癌细胞化疗增敏剂。
J Med Chem. 2024 Nov 28;67(22):20438-20454. doi: 10.1021/acs.jmedchem.4c01894. Epub 2024 Nov 17.
3
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities.
糖酵解在肿瘤发生中的作用:从生物学角度到治疗机会。
Neoplasia. 2024 Dec;58:101076. doi: 10.1016/j.neo.2024.101076. Epub 2024 Oct 30.
4
Coumarin-Based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 Inhibitors.香豆素类醛酮还原酶家族 1C(AKR1C)2 和 3 抑制剂。
ChemMedChem. 2024 Nov 4;19(21):e202400081. doi: 10.1002/cmdc.202400081. Epub 2024 Sep 16.
5
Discovery of a New Class of 1-(4-Sulfamoylbenzoyl)piperidine-4-carboxamides as Human Carbonic Anhydrase Inhibitors.新型1-(4-氨磺酰基苯甲酰基)哌啶-4-甲酰胺类化合物作为人碳酸酐酶抑制剂的发现
ACS Med Chem Lett. 2024 Mar 13;15(4):470-477. doi: 10.1021/acsmedchemlett.3c00484. eCollection 2024 Apr 11.
6
Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffold.基于功能化香豆素骨架的碳酸酐酶 IX 和 XII 选择性抑制剂。
Drug Dev Res. 2023 Jun;84(4):681-702. doi: 10.1002/ddr.22049. Epub 2023 Mar 5.
7
Phenylsulfonimide PPARα Antagonists Enhance Nrf2 Activation and Promote Oxidative Stress-Induced Apoptosis/Pyroptosis in MCF7 Breast Cancer Cells.苯磺酰亚胺 PPARα 拮抗剂增强 Nrf2 激活并促进 MCF7 乳腺癌细胞氧化应激诱导的细胞凋亡/细胞焦亡。
Int J Mol Sci. 2023 Jan 10;24(2):1316. doi: 10.3390/ijms24021316.
8
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors.关于肼基苯磺酰胺类化合物作为人碳酸酐酶 I、II、IX 和 XII 抑制剂的研究。
Molecules. 2022 Dec 22;28(1):91. doi: 10.3390/molecules28010091.
9
Natural and Synthetic Xanthone Derivatives Counteract Oxidative Stress via Nrf2 Modulation in Inflamed Human Macrophages.天然和合成的黄烷酮衍生物通过调节 Nrf2 减轻炎症状态下人巨噬细胞的氧化应激。
Int J Mol Sci. 2022 Nov 1;23(21):13319. doi: 10.3390/ijms232113319.
10
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity.含哌啶基-酰肼脲基和哌啶基-酰肼硫脲基部分的磺酰胺的合成及其对碳酸酐酶 I、II、IX 和 XII 的抑制活性。
Molecules. 2022 Aug 23;27(17):5370. doi: 10.3390/molecules27175370.